CERE
HSBC Holdings’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-529,071
| Closed | -$21.7M | – | 2775 |
|
|
2024
Q2 | $21.7M | Buy |
529,071
+121,261
| +30% | +$4.98M | 0.01% | 603 |
|
|
2024
Q1 | $17.2M | Sell |
407,810
-222
| -0.1% | -$9.38K | 0.01% | 671 |
|
|
2023
Q4 | $17.3M | Buy |
+408,032
| New | +$17.3M | 0.02% | 647 |
|
|
2021
Q2 | – | Sell |
-10,518
| Closed | -$140K | – | 2610 |
|
|
2021
Q1 | $140K | Sell |
10,518
-10,485
| -50% | -$140K | ﹤0.01% | 2227 |
|
|
2020
Q4 | $357K | Buy |
+21,003
| New | +$357K | ﹤0.01% | 2034 |
|